Clinical Trial Update: Phase I Randomized, Open-label, Parallel-controlled, Pharmacokinetic and Safety Study of BR201 Injection Versus Cosentyx in Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase I randomized PK and safety study comparing BR201 injection to Cosentyx in healthy male subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• BR201
• Cosentyx (secukinumab)

Snippet

Sponsor: BioRay Pharmaceutical Co., Ltd. | Conditions: Psoriasis | Phase 1 | Status: COMPLETED